Q32 Bio (QTTB) Stock Chart & Stock Price History $2.21 -0.10 (-4.33%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$2.20 -0.01 (-0.45%) As of 07/25/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Q32 Bio Stock Price Performance The Q32 Bio (QTTB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 93.90%, with a year-to-date return of -35.76%. In the past month, the stock has increased 42.58%, reflecting recent market activity. As of the latest close, Q32 Bio traded at $2.21 with a market cap of $26.96 million and volume of 213,148 shares. Receive QTTB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Q32 Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.38%1 Month Performance+42.58%3 Month Performance+18.18%Year-To-Date Performance-35.76%1 Year Performance-93.90% QTTB Stock Chart for Saturday, July, 26, 2025 QTTB Chart by TradingView Q32 Bio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/25/2025$2.31$2.21-4.33%$2.34$2.13213,148 shs$26.96 million07/24/2025$2.34$2.31-1.28%$2.40$2.25182,829 shs$28.18 million07/23/2025$2.24$2.34+4.46%$2.34$2.20369,701 shs$28.54 million07/22/2025$2.18$2.24+2.75%$2.33$2.08602,998 shs$27.33 million07/21/2025$2.19$2.18-0.46%$2.30$2.13276,429 shs$26.60 million07/18/2025$2.32$2.19-5.60%$2.42$2.15609,599 shs$26.72 million07/17/2025$2.78$2.32-16.55%$2.80$2.251.53 million shs$28.30 million07/16/2025$2.08$2.78+33.65%$2.96$2.084.25 million shs$33.92 million07/15/2025$2.03$2.08+2.46%$2.18$1.85775,781 shs$25.38 million07/14/2025$2.66$2.03-23.68%$2.69$1.902.17 million shs$24.77 million Get the Latest News and Ratings for QTTB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Q32 Bio and its competitors with MarketBeat's FREE daily newsletter. 07/11/2025$3.32$2.66-19.88%$3.08$2.514.02 million shs$32.45 million07/10/2025$1.51$3.32+119.87%$3.75$1.5459.27 million shs$40.50 million07/09/2025$1.39$1.51+8.63%$1.51$1.41133,331 shs$18.42 million07/08/2025$1.36$1.39+2.21%$1.43$1.35105,510 shs$16.96 million07/07/2025$1.44$1.36-5.56%$1.44$1.35137,303 shs$16.59 million07/04/2025$1.44$1.44$1.46$1.4052,824 shs$17.57 million07/03/2025$1.44$1.44$1.46$1.4052,824 shs$17.57 million07/02/2025$1.44$1.44$1.50$1.4349,707 shs$17.57 million07/01/2025$1.49$1.44-3.36%$1.51$1.4153,729 shs$17.57 million06/30/2025$1.45$1.49+2.76%$1.57$1.4560,426 shs$18.18 million06/27/2025$1.55$1.45-6.45%$1.63$1.45928,603 shs$17.69 million06/26/2025$1.56$1.55-0.64%$1.62$1.4978,071 shs$18.91 million06/25/2025$1.59$1.56-1.89%$1.64$1.5642,306 shs$19.03 million Related Companies Zentalis Pharmaceuticals Stock Chart OptiNose Stock Chart Whitehawk Therapeutics Stock Chart Contineum Therapeutics Stock Chart Climb Bio Stock Chart Vaxart Stock Chart BeyondSpring Stock Chart Virios Therapeutics Stock Chart OncoCyte Stock Chart ImmunoPrecise Antibodies Stock Chart Receive QTTB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Q32 Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:QTTB) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredStrait of Hormuz = $100 Oil?Dow Drops 540 Points, Oil Soars Middle East conflict sends markets plunging, oil jumping 8.5%. Investors fl...The Oxford Club | SponsoredThe AI Chip Trade is OUT. This is in…Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredElon Musk: “This will transform civilization as we know it.”Robots are no longer science fiction — they’re the next trillion-dollar megatrend. According to Forbes, by ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Q32 Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Q32 Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
